Nadler Financial Group’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.94M | Buy |
7,729
+198
| +3% | +$42.6K | 0.16% | 44 |
|
|
2026
Q1 | $1.64M | Sell |
7,531
-896
| -11% | -$199K | 0.16% | 46 |
|
|
2025
Q4 | $1.93M | Sell |
8,427
-252
| -3% | -$57.4K | 0.18% | 44 |
|
|
2025
Q3 | $2.01M | Sell |
8,679
-205
| -2% | -$41.7K | 0.19% | 40 |
|
|
2025
Q2 | $1.65M | Sell |
8,884
-586
| -6% | -$109K | 0.17% | 44 |
|
|
2025
Q1 | $1.98M | Sell |
9,470
-109
| -1% | -$21.2K | 0.22% | 41 |
|
|
2024
Q4 | $1.7M | Sell |
9,579
-10
| -0.1% | -$1.84K | 0.18% | 41 |
|
|
2024
Q3 | $1.89M | Sell |
9,589
-30
| -0.3% | -$5.6K | 0.21% | 41 |
|
|
2024
Q2 | $1.65M | Sell |
9,619
-161
| -2% | -$26.7K | 0.19% | 41 |
|
|
2024
Q1 | $1.78M | Sell |
9,780
-36
| -0.4% | -$6.2K | 0.22% | 39 |
|
|
2023
Q4 | $1.52M | Sell |
9,816
-4,107
| -29% | -$599K | 0.2% | 38 |
|
|
2023
Q3 | $2.08M | Sell |
13,923
-87
| -0.6% | -$12.8K | 0.31% | 34 |
|
|
2023
Q2 | $1.89M | Sell |
14,010
-1,183
| -8% | -$173K | 0.28% | 35 |
|
|
2023
Q1 | $2.42M | Buy |
15,193
+7
| +0% | +$1.07K | 0.39% | 31 |
|
|
2022
Q4 | $2.45M | Sell |
15,186
-793
| -5% | -$122K | 0.43% | 29 |
|
|
2022
Q3 | $2.15M | Buy |
15,979
+76
| +0.5% | +$10.9K | 0.41% | 31 |
|
|
2022
Q2 | $2.44M | Buy |
15,903
+52
| +0.3% | +$7.95K | 0.45% | 30 |
|
|
2022
Q1 | $2.57M | Sell |
15,851
-1,196
| -7% | -$174K | 0.4% | 30 |
|
|
2021
Q4 | $2.31M | Buy |
17,047
+319
| +2% | +$37.7K | 0.34% | 34 |
|
|
2021
Q3 | $1.8M | Buy |
16,728
+837
| +5% | +$95.6K | 0.29% | 38 |
|
|
2021
Q2 | $1.79M | Buy |
15,891
+405
| +3% | +$45.6K | 0.29% | 35 |
|
|
2021
Q1 | $1.68M | Buy |
15,486
+413
| +3% | +$44.2K | 0.3% | 36 |
|
|
2020
Q4 | $1.61M | Sell |
15,073
-1,940
| -11% | -$186K | 0.31% | 35 |
|
|
2020
Q3 | $1.49M | Sell |
17,013
-112
| -0.7% | -$10.5K | 0.33% | 33 |
|
|
2020
Q2 | $1.68M | Buy |
17,125
+2,180
| +15% | +$192K | 0.42% | 29 |
|
|
2020
Q1 | $1.14M | Sell |
14,945
-256
| -2% | -$21.8K | 0.35% | 30 |
|
|
2019
Q4 | $1.35M | Buy |
15,201
+5,628
| +59% | +$467K | 0.33% | 31 |
|
|
2019
Q3 | $725K | Sell |
9,573
-5
| -0.1% | -$343 | 0.2% | 41 |
|
|
2019
Q2 | $697K | Sell |
9,578
-505
| -5% | -$39.7K | 0.2% | 42 |
|
|
2019
Q1 | $813K | Sell |
10,083
-1,180
| -10% | -$96.5K | 0.26% | 39 |
|
|
2018
Q4 | $1.04M | Sell |
11,263
-923
| -8% | -$81.2K | 0.34% | 29 |
|
|
2018
Q3 | $1.15M | Sell |
12,186
-35
| -0.3% | -$3.32K | 0.31% | 32 |
|
|
2018
Q2 | $1.13M | Buy |
12,221
+1,167
| +11% | +$114K | 0.32% | 32 |
|
|
2018
Q1 | $1.05M | Sell |
11,054
-793
| -7% | -$87.1K | 0.32% | 30 |
|
|
2017
Q4 | $1.15M | Buy |
11,847
+703
| +6% | +$66.3K | 0.35% | 30 |
|
|
2017
Q3 | $990K | Buy |
11,144
+54
| +0.5% | +$4.11K | 0.33% | 31 |
|
|
2017
Q2 | $804K | Buy |
11,090
+3
| +0% | +$202 | 0.27% | 34 |
|
|
2017
Q1 | $722K | Sell |
11,087
-267
| -2% | -$16.8K | 0.25% | 36 |
|
|
2016
Q4 | $711K | Buy |
11,354
+182
| +2% | +$11.1K | 0.26% | 35 |
|
|
2016
Q3 | $705K | Buy |
11,172
+1,369
| +14% | +$88.6K | 0.28% | 33 |
|
|
2016
Q2 | $607K | Buy |
9,803
+3
| +0% | +$183 | 0.26% | 37 |
|
|
2016
Q1 | $560K | Buy |
9,800
+104
| +1% | +$5.8K | 0.24% | 39 |
|
|
2015
Q4 | $574K | Sell |
9,696
-729
| -7% | -$42K | 0.26% | 37 |
|
|
2015
Q3 | $567K | Buy |
10,425
+69
| +0.7% | +$4.49K | 0.28% | 36 |
|
|
2015
Q2 | $696K | Buy |
10,356
+3,096
| +43% | +$202K | 0.33% | 33 |
|
|
2015
Q1 | $425K | Sell |
7,260
-415
| -5% | -$25.1K | 0.2% | 45 |
|
|
2014
Q4 | $502K | Buy |
7,675
+187
| +2% | +$11.8K | 0.26% | 42 |
|
|
2014
Q3 | $433K | Sell |
7,488
-26
| -0.3% | -$1.44K | 0.26% | 40 |
|
|
2014
Q2 | $424K | Sell |
7,514
-100
| -1% | -$5.25K | 0.27% | 37 |
|
|
2014
Q1 | $391K | Hold |
7,614
| – | – | 0.26% | 42 |
|
|
2013
Q4 | $402K | Hold |
7,614
| – | – | 0.26% | 43 |
|
|
2013
Q3 | $341K | Sell |
7,614
-1,349
| -15% | -$59.8K | 0.25% | 48 |
|
|
2013
Q2 | $371K | Buy |
+8,963
| New | +$392K | 0.26% | 46 |
|
Other funds holding ABBV
ECSS
ATO
Nadler Financial Group's ABBV Position: Q2 2026 in Review
Nadler Financial Group increased its AbbVie (ABBV) stake by 2.6% in Q2 2026, buying an estimated $42.6K and bringing the position to 7,729 shares worth $1.94M. The position accounts for 0.16% of the portfolio, ranked #44.
Nadler Financial Group first reported a position in ABBV in Q2 2013 and has held it in 53 quarters since. The position peaked at $2.57M in Q1 2022. 2,121 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.
- Nadler Financial Group held 7,729 shares of AbbVie worth $1.94M as of Q2 2026.
- Nadler Financial Group bought 198 AbbVie shares in Q2 2026, an estimated $42.6K.
- AbbVie made up 0.16% of Nadler Financial Group's portfolio in Q2 2026, its #44 holding.
- Nadler Financial Group first reported a position in AbbVie in Q2 2013 and has held it in 53 quarters since.
- Nadler Financial Group's AbbVie position peaked at $2.57M in Q1 2022.
- 2,121 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.
Based on Nadler Financial Group's 13F filing for Q2 2026, filed 30 Jul 2026.